Stanford, CA, United States of America

Stephen J Galli

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Leland Stanford Junior University, Other. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen J Galli. Retrieved from https://idiyas.com/inventor/stephen-j-galli-begqymbq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Stanford, CA (US) (2013)
  • Portola Valley, CA (US) (2002 - 2023)

Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Stephen J. Galli

Introduction

Stephen J. Galli is a prominent inventor based in Stanford, CA (US). He has made significant contributions to the field of biomedical research, particularly in the areas of antibody detection and sepsis. With a total of 5 patents, Galli's work has had a profound impact on understanding and diagnosing various medical conditions.

Latest Patents

One of Galli's latest patents is focused on multiplex isotype-specific antibody detection. This invention discloses methods and reagents for the multiplex detection of antibodies using antigen-DNA and antibody-binding agent-DNA conjugates that carry DNA barcodes. This innovative approach allows for the identification and quantification of disease-relevant antibody isotypes, which are crucial in understanding allergic responses, autoimmune diseases, infections, and inflammation.

Another significant patent by Galli addresses neurotensin as a marker and therapeutic target for sepsis. Sepsis is a complex and often fatal disorder characterized by a dysregulated host response to infection. Galli's research demonstrates that plasma concentrations of neurotensin (NT) are increased in humans with sepsis. His findings indicate that mast cells can regulate NT concentrations, identifying NT as a potential biomarker and therapeutic target in sepsis.

Career Highlights

Stephen J. Galli has worked at Leland Stanford Junior University, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of immune responses and their implications in health and disease.

Collaborations

Galli has collaborated with notable colleagues, including Mindy Tsai and See-Ying Tam. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Stephen J. Galli's innovative work in antibody detection and sepsis highlights his significant contributions to biomedical research. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…